North America Atherectomy Devices Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Directional Atherectomy Devices, Rotational Atherectomy Devices, Orbital Atherectomy Devices, Laser Atherectomy Devices, and Others), By Application (Peripheral Vascular Applications, Cardiovascular Applications, and Others) and North America Atherectomy Devices Market Insights, Industry Trend, Forecasts to 2035

North America Atherectomy Devices Market Insights Forecasts to 2035

• The North America Atherectomy Devices Market Size Was Estimated at USD 0.68 Billion in 2025
• The Market Size is Expected to Grow at a CAGR of Around 6.45 % from 2026 to 2035
• The North America Atherectomy Devices Market Size is Expected to Reach USD 1.27 Billion by 2035

According to a research report published by Spherical Insights & Consulting, the North America Atherectomy Devices market size is anticipated to reach USD 1.27 billion by 2035, growing at a CAGR of 6.45 % from 2026 to 2035. The Atherectomy Devices market in North America is driven by increasing prevalence of cardiovascular diseases, rising incidence of peripheral artery disease, growing preference for minimally invasive procedures, technological advancements in plaque removal devices, and favorable reimbursement policies.

Market Overview

North America atherectomy devices market is defined as the industry dealing with the production, development, and commercialization of medical instruments utilized in the procedure of removing atherosclerotic deposits in the arteries of individuals. This process aims at treating patients with peripheral artery disease and coronary artery disease. Through atherectomy procedures, arterial blockage and improved circulation in arteries are achieved.

This market is experiencing rapid growth owing to high prevalence rates of cardiovascular diseases, obesity, diabetes, hypertension, and aging demographics among populations in Canada and the United States. These atherectomy devices are effective solutions for patients suffering from heavily calcified lesions through procedures other than angioplasty treatments. New developments in directional, rotational, orbital, and laser atherectomy systems have been enhancing outcomes and improving patient safety.

Besides, trends towards performing vascular surgeries outside hospital settings, the growth in the adoption rate of ambulatory surgery centers, and increased awareness about early detection and treatment of vascular diseases are expected to create numerous market opportunities.

Report Coverage

This research report categorizes the market for the North America Atherectomy Devices market based on various segments and regions, and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the North America Atherectomy Devices market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the North America Atherectomy Devices market.

Driving Factors

The growth of North America atherectomy devices market is due to the increasing incidences of PAD, CAD, diabetes, obesity, and hypertension. The increase in the number of aging population, increasing demand for minimal vascular treatments, favorable reimbursement policies, and continuous technological innovations in atherectomy devices are some other factors driving the market growth. Moreover, increasing knowledge about vascular health, rise in the number of ambulatory care centers, and increasing healthcare spending are boosting the use of atherectomy devices.

Restraining Factors

The market growth is restrained by the high cost of atherectomy procedures and devices, risk of procedural complications, stringent regulatory requirements, and limited availability of skilled vascular specialists. Additionally, competition from alternative treatment options such as angioplasty and stenting may hinder market expansion.

Market Segmentation

The North America Atherectomy Devices market share is classified into product type and application.

• The directional atherectomy devices segment accounted for the largest revenue market share in 2025 and is expected to grow at a significant CAGR during the forecast period. 

The North America atherectomy devices market is segmented by product type into directional atherectomy devices, rotational atherectomy devices, orbital atherectomy devices, laser atherectomy devices, and others. Among these, the directional atherectomy devices segment accounted for the largest revenue market share in 2025 and is expected to grow at a significant CAGR during the forecast period. This dominance is attributed to their effectiveness in removing plaque from peripheral arteries, increasing physician preference, improved procedural precision, reduced vessel trauma, and growing utilization in peripheral vascular interventions. Furthermore, ongoing technological advancements and favorable clinical outcomes are supporting segment growth.

• The peripheral vascular applications segment dominated the share in 2025 and is anticipated to grow at a remarkable CAGR during the forecast period. 

The North America atherectomy devices market is segmented by application into peripheral vascular applications, cardiovascular applications, and others. Among these, the peripheral vascular applications segment dominated the share in 2025 and is anticipated to grow at a remarkable CAGR during the forecast period. The growth is driven by the increasing prevalence of peripheral artery disease, rising geriatric population, growing incidence of diabetes and obesity, and increasing demand for minimally invasive treatment procedures. Additionally, improved diagnostic capabilities, growing awareness regarding PAD management, and favorable reimbursement policies are contributing significantly to segment expansion.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the North America Atherectomy Devices market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Abbott Laboratories
• Boston Scientific Corporation
• Medtronic plc
• Cardiovascular Systems, Inc.
• Philips Healthcare
• Avinger, Inc.
• Becton, Dickinson and Company
• Johnson & Johnson MedTech
• AngioDynamics, Inc.
• Terumo Corporation
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments:

• In September 2025, Abbott Laboratories announced enhancements in its vascular treatment solutions aimed at improving outcomes for patients with peripheral artery disease.
• In February 2025, Boston Scientific Corporation expanded its peripheral intervention portfolio with advanced plaque modification technologies for complex vascular lesions.

Market Segment

This study forecasts revenue at the North America, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the North America Atherectomy Devices market based on the below-mentioned segments:

North America Atherectomy Devices Market, By Product Type

• Directional Atherectomy Devices
• Rotational Atherectomy Devices
• Orbital Atherectomy Devices
• Laser Atherectomy Devices
• Others

North America Atherectomy Devices Market, By Application

• Peripheral Vascular Applications
• Cardiovascular Applications
• Others